Abstract
Aiming at the development of a stable drug carrier for bicalutamide (BT), we prepared various lipid nano-emulsions (LNEs) from a lipid mixture of soybean oil, phosphatidylcholine, sodium palmitate and sucrose palmitate (SP). These LNEs had mean particle size of approximately 50 nm and zeta potential (ζ) of -40 to -30 mV and were investigated their stability in saline solution and in bovine serum by using the dynamic light scattering method. In saline solution, while the droplet size of LNEs without and with BT reached more than 150 nm, that of the BT-encapsulated LNEs with SP could be maintained within 100 nm even after 24 h. In contrast, the droplet size of LNEs hardly increased even over 72 h placed in bovine serum, suggesting that bovine serum albumin (BSA) suppressed their coalescence. The intrinsic fluorescence of BSA was quenched and blue-shifted in the presence of LNE. In addition, the ζ values of all LNEs increased to around -20 mV according to the increase of BSA concentration. These results demonstrated that BSA interacted with LNE particles. Furthermore, the fluorescence resonance energy transfer using a fluorescence probe revealed that not only BT encapsulated in LNE particles but also SP strongly interacted with BSA.
Keywords: Lipid nano-emulsion, bicalutamide, bovine serum albumin, interaction, stability, sucrose palmitate
Current Nanoscience
Title:Effect of Bovine Serum Albumin on the Stability of Bicalutamide-Encapsulated Lipid Nano-Emulsion in Bovine Serum
Volume: 8 Issue: 2
Author(s): Shigehiko Takegami, Shoko Uchida, Eriko Aoi, Takumi Yamamoto, Aki Yasuhara, Madoka Fujihara, Kaori Hayashi and Tatsuya Kitade
Affiliation:
Keywords: Lipid nano-emulsion, bicalutamide, bovine serum albumin, interaction, stability, sucrose palmitate
Abstract: Aiming at the development of a stable drug carrier for bicalutamide (BT), we prepared various lipid nano-emulsions (LNEs) from a lipid mixture of soybean oil, phosphatidylcholine, sodium palmitate and sucrose palmitate (SP). These LNEs had mean particle size of approximately 50 nm and zeta potential (ζ) of -40 to -30 mV and were investigated their stability in saline solution and in bovine serum by using the dynamic light scattering method. In saline solution, while the droplet size of LNEs without and with BT reached more than 150 nm, that of the BT-encapsulated LNEs with SP could be maintained within 100 nm even after 24 h. In contrast, the droplet size of LNEs hardly increased even over 72 h placed in bovine serum, suggesting that bovine serum albumin (BSA) suppressed their coalescence. The intrinsic fluorescence of BSA was quenched and blue-shifted in the presence of LNE. In addition, the ζ values of all LNEs increased to around -20 mV according to the increase of BSA concentration. These results demonstrated that BSA interacted with LNE particles. Furthermore, the fluorescence resonance energy transfer using a fluorescence probe revealed that not only BT encapsulated in LNE particles but also SP strongly interacted with BSA.
Export Options
About this article
Cite this article as:
Takegami Shigehiko, Uchida Shoko, Aoi Eriko, Yamamoto Takumi, Yasuhara Aki, Fujihara Madoka, Hayashi Kaori and Kitade Tatsuya, Effect of Bovine Serum Albumin on the Stability of Bicalutamide-Encapsulated Lipid Nano-Emulsion in Bovine Serum, Current Nanoscience 2012; 8 (2) . https://dx.doi.org/10.2174/157341312800167579
DOI https://dx.doi.org/10.2174/157341312800167579 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Subject Index To Volune 2
Current Cancer Therapy Reviews A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets Versatile Applications of microRNA in Anti-Cancer Drug Discovery: From Therapeutics to Biomarkers
Current Drug Discovery Technologies Capillary Electrophoresis–Mass Spectrometry in Metabolomics: The Potential for Driving Drug Discovery and Development
Current Drug Metabolism Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition
Current Medicinal Chemistry Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
Current Cancer Drug Targets Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents
Current Protein & Peptide Science Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology
Current Drug Discovery Technologies Potential Cancer Gene Therapy by Baculoviral Transduction
Current Gene Therapy Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention
Current Drug Targets Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets Expression and Characterisation of Recombinant Molecules in Transgenic Soybean
Current Pharmaceutical Design Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Current Cancer Therapy Reviews Biomedical Applications of Carbon Nanotubes: A Critical Review
Current Drug Delivery General Theory for Multiple Input-Output Perturbations in Complex Molecular Systems. 1. Linear QSPR Electronegativity Models in Physical, Organic, and Medicinal Chemistry
Current Topics in Medicinal Chemistry